159 related articles for article (PubMed ID: 25573962)
1. Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
Scully OJ; Yu Y; Salim A; Thike AA; Yip GW; Baeg GH; Tan PH; Matsumoto K; Bay BH
Exp Biol Med (Maywood); 2015 Jul; 240(7):846-53. PubMed ID: 25573962
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
Lwin ZM; Guo C; Salim A; Yip GW; Chew FT; Nan J; Thike AA; Tan PH; Bay BH
Mod Pathol; 2010 Dec; 23(12):1559-66. PubMed ID: 20834237
[TBL] [Abstract][Full Text] [Related]
4. Interactome analysis reveals that C1QBP (complement component 1, q subcomponent binding protein) is associated with cancer cell chemotaxis and metastasis.
Zhang X; Zhang F; Guo L; Wang Y; Zhang P; Wang R; Zhang N; Chen R
Mol Cell Proteomics; 2013 Nov; 12(11):3199-209. PubMed ID: 23924515
[TBL] [Abstract][Full Text] [Related]
5. Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
Zhong J; Cao RX; Liu JH; Liu YB; Wang J; Liu LP; Chen YJ; Yang J; Zhang QH; Wu Y; Ding WJ; Hong T; Xiao XH; Zu XY; Wen GB
Oncogene; 2014 Nov; 33(48):5546-58. PubMed ID: 24292672
[TBL] [Abstract][Full Text] [Related]
6. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.
Qian L; Gao X; Huang H; Lu S; Cai Y; Hua Y; Liu Y; Zhang J
Oncotarget; 2017 Mar; 8(13):21444-21453. PubMed ID: 28423522
[TBL] [Abstract][Full Text] [Related]
7. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
[TBL] [Abstract][Full Text] [Related]
8. Fucosyltransferase 8 expression in breast cancer patients: A high throughput tissue microarray analysis.
Yue L; Han C; Li Z; Li X; Liu D; Liu S; Yu H
Histol Histopathol; 2016 May; 31(5):547-55. PubMed ID: 26596733
[TBL] [Abstract][Full Text] [Related]
9. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
Shi H; Fang W; Liu M; Fu D
Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of GLTSCR2 expression is correlated with breast cancer progression.
Moon A; Lim SJ; Jo YH; Lee S; Kim JY; Lee J; Park JH
Pathol Res Pract; 2013 Nov; 209(11):700-4. PubMed ID: 24054033
[TBL] [Abstract][Full Text] [Related]
11. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways.
Scully OJ; Shyamasundar S; Matsumoto K; Dheen ST; Yip GW; Bay BH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674861
[TBL] [Abstract][Full Text] [Related]
12. Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.
Oka K; Suzuki T; Onodera Y; Miki Y; Takagi K; Nagasaki S; Akahira J; Ishida T; Watanabe M; Hirakawa H; Ohuchi N; Sasano H
Int J Cancer; 2011 Apr; 128(8):1770-82. PubMed ID: 20533549
[TBL] [Abstract][Full Text] [Related]
13. Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.
Chua PJ; Lee EH; Yu Y; Yip GW; Tan PH; Bay BH
Int J Oncol; 2010 Feb; 36(2):359-64. PubMed ID: 20043069
[TBL] [Abstract][Full Text] [Related]
14. NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.
Lv ZD; Zhang L; Liu XP; Jin LY; Dong Q; Li FN; Wang HB; Kong B
Int J Clin Exp Pathol; 2015; 8(4):4015-21. PubMed ID: 26097589
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HOXD13 expression in human breast cancer.
Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
[TBL] [Abstract][Full Text] [Related]
16. [Expression of C1QBP gene and its correlation with drug resistance in human resistance choriocarcinoma cell line].
Shen X; Han B; Shen Y; Yang J; Ren T; Sha G; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):616-20. PubMed ID: 25354864
[TBL] [Abstract][Full Text] [Related]
17. E2F-1: a proliferative marker of breast neoplasia.
Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
[TBL] [Abstract][Full Text] [Related]
18. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
19. Expression status of cyclase‑associated protein 2 as a prognostic marker for human breast cancer.
Xu L; Peng S; Huang Q; Liu Y; Jiang H; Li X; Wang J
Oncol Rep; 2016 Oct; 36(4):1981-8. PubMed ID: 27573674
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
